Chrysin alleviated CUMS-induced depressive-like behaviors in mice via directly targeting Fyn

[1]  Yi-hua Yu,et al.  A20, as a downstream factor of Nrf2, is involved in the anti-neuroinflammatory and antidepressant-like effects of luteolin , 2022, Journal of Functional Foods.

[2]  Jie‐Kun Xu,et al.  The NLRP3 inflammasome in depression: Potential mechanisms and therapies. , 2022, Pharmacological research.

[3]  Ying He,et al.  Biology of cyclooxygenase-2: An application in depression therapeutics , 2022, Frontiers in Psychiatry.

[4]  Zhipeng Li,et al.  Chrysin alleviates lipopolysaccharide-induced neuron damage and behavioral deficits in mice through inhibition of Fyn. , 2022, International immunopharmacology.

[5]  G. Wang,et al.  Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression , 2022, Journal of neuroinflammation.

[6]  L. Mao,et al.  Roles of non-receptor tyrosine kinases in pathogenesis and treatment of depression , 2022, Journal of integrative neuroscience.

[7]  Bo Zhu,et al.  Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification , 2020, Signal Transduction and Targeted Therapy.

[8]  A. Cressant,et al.  Neuroinflammation and depression: A review , 2020, The European journal of neuroscience.

[9]  E. Tuzun,et al.  Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes , 2019, Brain Research.

[10]  Liyan Wang,et al.  COX-2 inhibition rescues depression-like behaviors via suppressing glial activation, oxidative stress and neuronal apoptosis in rats , 2019, Neuropharmacology.

[11]  T. Dawson,et al.  Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia , 2019, The Journal of experimental medicine.

[12]  Li-yuan Cui,et al.  A20 as a novel target for the anti-neuroinflammatory effect of chrysin via inhibition of NF-κB signaling pathway , 2019, Brain, Behavior, and Immunity.

[13]  Minoru Yoshida.  Recent advances in target identification of bioactive natural products , 2019, Bioscience, biotechnology, and biochemistry.

[14]  Qi Chen,et al.  Cyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the Pathophysiological Mechanisms in the Rat Model of Depression , 2017, Scientific Reports.

[15]  Karunakaran A Kalesh,et al.  Target identification of natural and traditional medicines with quantitative chemical proteomics approaches. , 2016, Pharmacology & therapeutics.

[16]  R. Torta,et al.  Disease-Induced Neuroinflammation and Depression. , 2016, CNS & neurological disorders drug targets.

[17]  R. Yirmiya,et al.  Depression as a Microglial Disease , 2015, Trends in Neurosciences.

[18]  L. Fabbro,et al.  Chronic unpredictable mild stress decreases BDNF and NGF levels and Na+,K+-ATPase activity in the hippocampus and prefrontal cortex of mice: Antidepressant effect of chrysin , 2015, Neuroscience.

[19]  Vellareddy Anantharam,et al.  Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease , 2014, The Journal of Neuroscience.

[20]  Eunjung Moon,et al.  Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-κB and JNK activations in microglia cells , 2010, Neuroscience Letters.

[21]  T. Miyakawa,et al.  Stress-Evoked Tyrosine Phosphorylation of Signal Regulatory Protein α Regulates Behavioral Immobility in the Forced Swim Test , 2010, The Journal of Neuroscience.

[22]  Mun Kyung Hwang,et al.  Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha. , 2009, Biochemical pharmacology.

[23]  Xia Zhang,et al.  Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor , 2008, Neuroscience Letters.